Diagnostic potential of total serum ghrelin in autoimmune gastritis: A systematic review and meta-analysis

TL;DR

This study reviews the potential of total serum ghrelin as a diagnostic marker for autoimmune gastritis, finding mixed results with significant differences in severe cases.

Contribution

The study provides a meta-analysis of serum ghrelin levels in autoimmune gastritis, highlighting its potential in moderate-to-severe cases.

Findings

Total serum ghrelin levels were not significantly different between AIG patients and healthy controls overall.

Significantly lower ghrelin levels were observed in patients with moderate-to-severe gastric atrophy.

BMI was identified as a major contributor to heterogeneity in the study results.

Abstract

Autoimmune gastritis (AIG) is a chronic inflammatory condition characterized by the destruction of gastric parietal cells. The invasive nature of diagnostic procedures and risk of confounding factors hinder the development of reliable diagnostic tools for AIG.

We conducted a systematic search of four databases. After assessing the study quality using the ROBINS-E tool, a meta-analysis was performed using a random-effects model. Meta-regression and sensitivity analyses were conducted to explore the sources of heterogeneity and impact of study bias,

The pooled mean difference in total serum ghrelin (pmol/L) between patients with AIG and healthy controls was −65.28 (95% CI: −178.54, 47.97). Subgroup analysis showed that the mean differences in serum ghrelin for mild, moderate, and severe atrophy were −78.85 (95% CI: −165.17, to 7.48), −91.97 (95% CI: −183.11, to −0.84), and −110.67 (95% CI: −204.77, to −16.56), respectively. The sensitivity analysis confirmed that the exclusion of studies with high-risk bias did not significantly alter the results. Meta-regression indicated that BMI contributed substantially to heterogeneity.

Although total serum ghrelin levels were not significantly different between patients with AIG and healthy controls, significantly lower levels were observed in patients with moderate-to-severe gastric atrophy. Given the high heterogeneity and limitations of existing studies, the diagnostic utility of serum ghrelin in AIG warrants further investigation.

Figures